(Q37677179)

21 August 2017

1 reference

title

Differential regulation of microglial motility by ATP/ADP and adenosine (English)

1 reference

21 August 2017

0 references

Stefka Gyoneva

1 reference

21 August 2017

Anna G Orr

1 reference

21 August 2017

Stephen F Traynelis

series ordinal

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Parkinsonism and Related Disorders

21 August 2017

published in

1 reference

21 August 2017

volume

15 Suppl 3

1 reference

21 August 2017

page(s)

S195-9

1 reference

Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Microglia as neuroprotective, immunocompetent cells of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

ATP mediates rapid microglial response to local brain injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Phagocytozing ameboid microglial cells studied in a mouse corpus callosum slice preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Diverse microglial motility behaviors during clearance of dead cells in hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine A(2A) receptor mediates microglial process retraction

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Chemotaxis by a CNS macrophage, the microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Epidermal Growth Factor is a Motility Factor for Microglial Cells In Vitro: Evidence for EGF Receptor Expression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Chemotaxis and accumulation of nerve growth factor by microglia and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor-3 and scavenger receptor-AI/II in microglia and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Cytokines, chemokines, and cytokine receptors in human microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Targeting adenosine A2A receptors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine A2A receptors modify motor function in MPTP-treated common marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970813-2

7 January 2021

10.1016/S1353-8020(09)70813-2

Identifiers

DOI

1 reference

21 August 2017

1 reference